
Xunsheng Biomedical
循生医学
Xunsheng Biomedical
Biotech/Healthcare
Xunsheng Medicine is an innovative biopharmaceutical company focused on cancer immunotherapy research. It develops biotechnology for tumor immunology drugs and novel personalized cancer immunotherapies, including immune cell therapies and therapeutic cancer vaccines such as cervical cancer vaccines.
Latest round: Series B Extension+ (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.